ISDA

Deposition Date 2024-01-18

Release Date 2024-09-11

Last Version Date 2024-09-25

Entry Detail

PDB ID:

8RQO

Keywords:

MEMBRANE PROTEIN

Title:

Human thyroid hormone receptor alpha ligand binding domain in complex with beta-selective agonist ALG-055009

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.74 Å

R-Value Free:

0.22

R-Value Work:

0.19

R-Value Observed:

0.19

Space Group:

P 65 2 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Isoform Alpha-1 of Thyroid hormone receptor alpha
Gene (Uniprot):THRA
Chain IDs:A
Chain Length:284
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P10827 Pfam ID:PF00104

Ligand Molecules

A1H2J

SO4

Primary Citation

Discovery and Preclinical Profile of ALG-055009, a Potent and Selective Thyroid Hormone Receptor Beta (THR-beta ) Agonist for the Treatment of MASH.

Vandyck, K, McGowan, D.C, Luong, X.G, Stevens, S.K, Jekle, A, Gupta, K, Misner, D.L, Chanda, S, Serebryany, V, Welch, M, Hu, H, Lv, Z, Williams, C, Maskos, K, Lammens, A, Stoycheva, A.D, Lin, T.I, Blatt, L.M, Beigelman, L.N, Symons, J.A, Raboisson, P, Deval, J.Show

J.Med.Chem. 67 14840 14851 (2024)

PMID: 39221768 DOI: 10.1021/acs.jmedchem.4c01029

Abstact

Agonists of thyroid hormone receptor β (THR-β) decreased LDL cholesterol (LDL-C) and triglyceride (TG) levels in human clinical trials for patients with dyslipidemia. The authors present the highly potent and selective compound ALG-055009 (14) as a potential best in class THR-β agonist. The high metabolic stability and good permeability translated well in vivo to afford a long in vivo half-life pharmacokinetic profile with limited liability for DDI, and it overcomes certain drawbacks seen in recent clinical candidates.

Legend

Protein

Chemical

Disease

Primary Citation of related structures